A Study of Elpipodect (MK-8189) Human Absorption, Metabolism, and Excretion in Healthy Male Parti… (NCT06626464) | Clinical Trial Compass
CompletedPhase 1
A Study of Elpipodect (MK-8189) Human Absorption, Metabolism, and Excretion in Healthy Male Participants (MK-8189-010)
United States6 participantsStarted 2022-05-13
Plain-language summary
The purpose of this study is to learn what happens to elpipodect in a healthy person's body over time.
Who can participate
Age range
18 Years – 55 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Key inclusion criteria include but are not limited to the following:
* Is in good health based on medical history, physical examination, VS measurements, and ECGs performed before randomization.
* Has a BMI ≥19 and ≤32 kg/m2, inclusive, at screening
Exclusion Criteria:
The key exclusion criteria include but are not limited to the following:
* Has a history of clinically significant endocrine, gastrointestinal (GI), cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological (including stroke and chronic seizures) abnormalities or diseases.
* Has a history of cancer.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Area Under the Concentration-Time Curve from 0 to 24 hours (AUC0-24) of Elpipodect
Timeframe: Predose and postdose up to 24 hours
2
Area Under the Concentration-Time Curve from Time 0 to Last (AUC0-Last) of Elpipodect
Timeframe: Predose and at designated timepoints up to Day 15
3
Area Under the Concentration-Time Curve from Time 0 to Infinity (AUC0-Inf) of Elpipodect
Timeframe: Predose and at designated timepoints up to Day 15
4
Maximum Concentration (Cmax) of Elpipodect
Timeframe: Predose and at designated timepoints up to Day 15
5
Apparent Half Life (t½) of Elpipodect
Timeframe: Predose and at designated timepoints up to Day 15
6
Time to Reach Maximum Concentration (Tmax) of Elpipodect
Timeframe: Predose and at designated timepoints up to Day 15